Investment Stage

Focus Areas

About Investor

Jon Lim is a Partner at F-Prime Capital Partners based in Greater Boston, focusing on biotechnology investments across early-stage life sciences companies. He invests primarily in Seed, Series A, and Series B rounds, supporting companies that are developing innovative therapeutic solutions and cutting-edge biotech platforms. His work involves evaluating highly technical scientific startups and partnering with founders to translate early research into scalable clinical and commercial outcomes. Jon is particularly interested in breakthrough biotech innovations that can significantly impact patient care and address unmet medical needs. His typical investment range is between $500K and $10M, with an average check size around $5M. He plays an active role in guiding companies through complex scientific and regulatory pathways as they grow.